Iterum Therapeutics plc (ITRMF) Short term Debt (2018 - 2024)

Iterum Therapeutics' Short term Debt history runs 5 years deep, the most recent figure standing at $14.5 million for Q4 2024.

• In Q4 2024, Short term Debt changed N/A year-over-year to $14.5 million; the TTM figure through Dec 2024 stood at $14.5 million (changed N/A YoY), while the FY2024 annual figure was $14.5 million, changed N/A from the prior year.
• Short term Debt for Q4 2024 stood at $14.5 million, up from $13.7 million in the prior quarter.
• The five-year high for Short term Debt was $14.5 million in Q4 2024, with the low at $1.6 million in Q4 2021.
• The 3-year median for Short term Debt is $6.2 million (2020), against an average of $7.8 million.
• The sharpest annual moves came in 2020 and 2021: Short term Debt surged 185.36% in 2020, then tumbled 74.47% in 2021.
• Iterum Therapeutics' Short term Debt stood at $6.4 million in 2020, then sank by 74.47% to $1.6 million in 2021, then surged by 788.94% to $14.5 million in 2024.
• Business Quant data shows ITRMF's Short term Debt at $14.5 million in Q4 2024, $13.7 million in Q3 2024, and $13.0 million in Q2 2024.